These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32773031)

  • 1. Inhibition of striatonigral autophagy as a link between cannabinoid intoxication and impairment of motor coordination.
    Blázquez C; Ruiz-Calvo A; Bajo-Grañeras R; Baufreton JM; Resel E; Varilh M; Pagano Zottola AC; Mariani Y; Cannich A; Rodríguez-Navarro JA; Marsicano G; Galve-Roperh I; Bellocchio L; Guzmán M
    Elife; 2020 Aug; 9():. PubMed ID: 32773031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid-induced motor dysfunction
    Blázquez C; Ruiz-Calvo A; Bajo-Grañeras R; Baufreton JM; Resel E; Varilh M; Pagano Zottola AC; Mariani Y; Cannich A; Rodríguez-Navarro JA; Marsicano G; Galve-Roperh I; Bellocchio L; Guzmán M
    Autophagy; 2020 Dec; 16(12):2289-2291. PubMed ID: 32981464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoids inhibit striatonigral GABAergic neurotransmission in the mouse.
    Wallmichrath I; Szabo B
    Neuroscience; 2002; 113(3):671-82. PubMed ID: 12150787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unbalanced Inhibitory/Excitatory Responses in the Substantia Nigra Pars Reticulata Underlie Cannabinoid-Related Slowness of Movements.
    Báez-Cordero AS; Pimentel-Farfan AK; Peña-Rangel T; Rueda-Orozco PE
    J Neurosci; 2020 Jul; 40(30):5769-5784. PubMed ID: 32532888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy activation by novel inducers prevents BECN2-mediated drug tolerance to cannabinoids.
    Kuramoto K; Wang N; Fan Y; Zhang W; Schoenen FJ; Frankowski KJ; Marugan J; Zhou Y; Huang S; He C
    Autophagy; 2016 Sep; 12(9):1460-71. PubMed ID: 27305347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid-induced autophagy: Protective or death role?
    Costa L; Amaral C; Teixeira N; Correia-da-Silva G; Fonseca BM
    Prostaglandins Other Lipid Mediat; 2016 Jan; 122():54-63. PubMed ID: 26732541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered motor development following late gestational alcohol and cannabinoid exposure in rats.
    Breit KR; Zamudio B; Thomas JD
    Neurotoxicol Teratol; 2019; 73():31-41. PubMed ID: 30943441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake.
    Romero J; de Miguel R; Ramos JA; Fernández-Ruiz JJ
    Life Sci; 1998; 62(4):351-63. PubMed ID: 9450507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
    Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M
    Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel halogenated synthetic cannabinoids impair sensorimotor functions in mice.
    Bilel S; Tirri M; Arfè R; Ossato A; Trapella C; Serpelloni G; Neri M; Fattore L; Marti M
    Neurotoxicology; 2020 Jan; 76():17-32. PubMed ID: 31610187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnenolone does not interfere with the effects of cannabinoids on synaptic transmission in the cerebellum and the nucleus accumbens.
    Krohmer A; Brehm M; Auwärter V; Szabo B
    Pharmacol Res; 2017 Sep; 123():51-61. PubMed ID: 28655644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis: discrimination of "internal bliss"?
    Wiley JL
    Pharmacol Biochem Behav; 1999 Oct; 64(2):257-60. PubMed ID: 10515300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dose-dependent psychomotor effects of intravenous delta-9-tetrahydrocannabinol (Δ
    Boggs DL; Cortes-Briones JA; Surti T; Luddy C; Ranganathan M; Cahill JD; Sewell AR; D'Souza DC; Skosnik PD
    J Psychopharmacol; 2018 Dec; 32(12):1308-1318. PubMed ID: 30255720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of exogenous and endogenous cannabinoids on GABAergic neurotransmission between the caudate-putamen and the globus pallidus in the mouse.
    Engler B; Freiman I; Urbanski M; Szabo B
    J Pharmacol Exp Ther; 2006 Feb; 316(2):608-17. PubMed ID: 16214880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor actions of cannabinoids in the basal ganglia output nuclei.
    Sañudo-Peña MC; Tsou K; Walker JM
    Life Sci; 1999; 65(6-7):703-13. PubMed ID: 10462071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis and the brain.
    Iversen L
    Brain; 2003 Jun; 126(Pt 6):1252-70. PubMed ID: 12764049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease.
    Gómez-Gálvez Y; Palomo-Garo C; Fernández-Ruiz J; García C
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():200-8. PubMed ID: 25863279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cannabinoid-1 receptor is abundantly expressed in striatal striosomes and striosome-dendron bouquets of the substantia nigra.
    Davis MI; Crittenden JR; Feng AY; Kupferschmidt DA; Naydenov A; Stella N; Graybiel AM; Lovinger DM
    PLoS One; 2018; 13(2):e0191436. PubMed ID: 29466446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral effects of cannabinoid agents in animals.
    Chaperon F; Thiébot MH
    Crit Rev Neurobiol; 1999; 13(3):243-81. PubMed ID: 10803637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid receptor 2 activation decreases severity of cyclophosphamide-induced cystitis via regulating autophagy.
    Liu Q; Wu Z; Liu Y; Chen L; Zhao H; Guo H; Zhu K; Wang W; Chen S; Zhou N; Li Y; Shi B
    Neurourol Urodyn; 2020 Jan; 39(1):158-169. PubMed ID: 31729056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.